Does LENVATINIB Cause Reactive capillary endothelial proliferation? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Reactive capillary endothelial proliferation have been filed in association with LENVATINIB (Lenvima). This represents 0.0% of all adverse event reports for LENVATINIB.
5
Reports of Reactive capillary endothelial proliferation with LENVATINIB
0.0%
of all LENVATINIB reports
0
Deaths
0
Hospitalizations
How Dangerous Is Reactive capillary endothelial proliferation From LENVATINIB?
Of the 5 reports.
Is Reactive capillary endothelial proliferation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LENVATINIB. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does LENVATINIB Cause?
Diarrhoea (4,262)
Hypertension (4,152)
Fatigue (3,603)
Decreased appetite (3,257)
Malignant neoplasm progression (2,929)
Nausea (2,492)
Blood pressure increased (2,228)
Vomiting (1,962)
Asthenia (1,643)
Malaise (1,602)
What Other Drugs Cause Reactive capillary endothelial proliferation?
CAMRELIZUMAB (41)
CAPECITABINE (19)
CISPLATIN (19)
DOCETAXEL\DOCETAXEL ANHYDROUS (17)
OXALIPLATIN (11)
ATEZOLIZUMAB (10)
BEVACIZUMAB (10)
PEMBROLIZUMAB (7)
SINTILIMAB (7)
TORIPALIMAB (6)
Which LENVATINIB Alternatives Have Lower Reactive capillary endothelial proliferation Risk?
LENVATINIB vs LEPONEX
LENVATINIB vs LERCANIDIPINE
LENVATINIB vs LETAIRIS
LENVATINIB vs LETERMOVIR
LENVATINIB vs LETROZOLE